Nunyara Pharma Pty Ltd is a limited by shares Australian proprietary company. Located at NSW 2481 since 2018-04-26 the company is, as the updated on 2021-06-10 ABN database shows, registered. The company has been registered for Goods & Services Tax since 2016-10-01 until 2020-04-26. Earlier it had been registered for GST since 2014-10-23 to 2014-10-23. Known company numbers for Nunyara Pharma Pty Ltd are as follows: ACN - 602495394, Australian Business Number - 38602495394. Nunyara Pharma Pty Ltd has been the company name since 2018-11-26. Their official company name changed on 2020-09-02 to Elixinol Australia Pty Ltd. The company had used this name up until 2021-06-10. Additionally they had used Nunyara Pharma Pty Ltd from 2019-06-25 to 2020-09-02, Elixinol Pty Ltd from 2014-10-23 to 2019-06-25. This Australian proprietary company was previously located in NSW 2482 (from 2014-10-23 to 2018-04-26).
| Status | From | To |
|---|---|---|
| Active | 2014-10-23 | current |
| Name | From | To |
|---|---|---|
| Elixinol Wellness (corporate Services) Pty Ltd | 2021-06-10 | current |
| Elixinol Australia Pty Ltd | 2020-09-02 | 2021-06-10 |
| Nunyara Pharma Pty Ltd | 2019-06-25 | 2020-09-02 |
| Elixinol Pty. Ltd. | 2014-10-23 | 2019-06-25 |
| Location | From | To |
|---|---|---|
| NSW 2481 | 2018-04-26 | current |
| NSW 2482 | 2014-10-23 | 2018-04-26 |
| Status | From | To |
|---|---|---|
| Registered | 2016-10-01 | 2020-04-26 |
| Registered | 2014-10-23 | 2014-10-23 |
Advertisements
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.